About: Preventing and controlling dyskinesia in Parkinson's disease--a view of current knowledge and future opportunities

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Preventing and controlling dyskinesia in Parkinson's disease--a view of current knowledge and future opportunities Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on January 2008

Attributes	Values
rdf:type	Item
description	videnskabelig artikel (da) article científic (ca) articolo scientifico (it) artigo científico (pt) bilimsel makale (tr) vedecký článok (sk) vetenskaplig artikel (sv) vědecký článek (cs) wetenschappelijk artikel (nl) wissenschaftlicher Artikel (de) научни чланак (sr) article scientifique (fr) artículu científicu espublizáu en 2008 (ast) наукова стаття, опублікована в січні 2008 (uk) scientific article published on January 2008 (en) مقالة علمية نشرت في يناير 2008 (ar) գիտական հոդված հրատարակված 2008 թվականի հունվարին (hy)
publication date	wds:Q37264464-034FB92D-5716-49DA-B79F-AB15A7834B40
publication date	2008-01-01 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q37264464-73DED0E0-7C04-4A46-B171-C94B3838676A
language of work or name	English
cites work	wds:Q37264464-236914F7-70FA-4F6C-8655-F5591B2CBC53 wds:Q37264464-255B12F0-2B6C-4DC3-866A-6E0366F0704E wds:Q37264464-3176607B-729F-4808-88A4-AC5698068C1F wds:Q37264464-495DEE7B-5849-43BE-B6AC-AA9D0215D483 wds:Q37264464-6D8F3489-BF26-49F3-AD76-60077BB325B2 wds:Q37264464-80160D9B-FBD2-4C6F-9310-B11EB2C960E2 wds:Q37264464-81F5C2D1-2BAF-4DE1-94AA-FFDB87FE46D1 wds:Q37264464-89797735-383D-4175-832F-C9A5BDE03425 wds:Q37264464-8CD3C2BB-C4B9-4FFD-A3B0-4FCACA6055F3 wds:Q37264464-A0F28FC0-8DA3-413E-BCCD-43177972FB96 wds:Q37264464-A4C0DD89-AD14-4573-B213-D4337746E23B wds:Q37264464-A8D093E0-F6B4-4C44-894F-DBD20B93E122 wds:Q37264464-A99DF741-441B-42D6-92D8-F330155ADC6D wds:Q37264464-B569F211-09E9-420D-B147-C91A5FC09BF2 wds:Q37264464-C4C25D78-585C-4F6D-BA95-1F98CAFBDD69 wds:Q37264464-D216C38D-2E97-462F-A7E0-A730C571A008 wds:Q37264464-E6953A34-67B9-4B39-BA10-C56A769A0A3B wds:Q37264464-EC19E833-2CED-467F-B744-1144EA9B04FA wds:Q37264464-F4D5C186-20D7-4A6A-A15A-04B086DE3C70
cites work	A2A antagonists as novel non-dopaminergic therapy for motor dysfunction in PD A randomized, controlled trial of remacemide for motor fluctuations in Parkinson's disease Serotonin 5-HT1A agonist improves motor complications in rodent and primate parkinsonian models Cannabinoids reduce levodopa-induced dyskinesia in Parkinson's disease: a pilot study Levodopa-induced changes in synaptic dopamine levels increase with progression of Parkinson's disease: implications for dyskinesias Antiparkinsonian effect of a new selective adenosine A2A receptor antagonist in MPTP-treated monkeys. Randomized trial of the adenosine A(2A) receptor antagonist istradefylline in advanced PD. Industry forum: Progress in pursuit of therapeutic A2A antagonists: The adenosine A2A receptor selective antagonist KW6002: Research and development toward a novel nondopaminergic therapy for Parkinson's disease AMPA receptor blockade improves levodopa-induced dyskinesia in MPTP monkeys Effect of an Opiate Antagonist on Movement Disorders Dextromethorphan improves levodopa-induced dyskinesias in Parkinson's disease Increase of preproenkephalin mRNA levels in the putamen of Parkinson disease patients with levodopa-induced dyskinesias The origin of motor fluctuations in Parkinson's disease: importance of dopaminergic innervation and basal ganglia circuits. Translating A2A antagonist KW6002 from animal models to parkinsonian patients Duodenal levodopa infusion monotherapy vs oral polypharmacy in advanced Parkinson disease Differential effects of D1 and D2 agonists in MPTP-treated primates: functional implications for Parkinson's disease A multicenter randomized controlled trial of remacemide hydrochloride as monotherapy for PD The pharmacokinetics of intravenous and oral levodopa in patients with Parkinson's disease who exhibit on-off fluctuations Consequences of nigrostriatal denervation on the gamma-aminobutyric acidic neurons of substantia nigra pars reticulata and superior colliculus in parkinsonian syndromes
author name string	wds:Q37264464-A9BB1DD4-FCBF-4A73-B21F-1E08EC731202
author name string	Peter Jenner
rdfs:label	Preventing and controlling dyskinesia in Parkinson's disease--a view of current knowledge and future opportunities (en) Preventing and controlling dyskinesia in Parkinson's disease--a view of current knowledge and future opportunities (nl) Preventing and controlling dyskinesia in Parkinson's disease--a view of current knowledge and future opportunities (ast)
skos:prefLabel	Preventing and controlling dyskinesia in Parkinson's disease--a view of current knowledge and future opportunities (en) Preventing and controlling dyskinesia in Parkinson's disease--a view of current knowledge and future opportunities (nl) Preventing and controlling dyskinesia in Parkinson's disease--a view of current knowledge and future opportunities (ast)
name	Preventing and controlling dyskinesia in Parkinson's disease--a view of current knowledge and future opportunities (en) Preventing and controlling dyskinesia in Parkinson's disease--a view of current knowledge and future opportunities (nl) Preventing and controlling dyskinesia in Parkinson's disease--a view of current knowledge and future opportunities (ast)
title	wds:Q37264464-EBC61A48-5E28-403A-A1AC-71F3AB7F3AB0
title	Preventing and controlling dyskinesia in Parkinson's disease--a view of current knowledge and future opportunities (en)
page(s)	wds:Q37264464-C7AEB499-94FB-4E69-AEAE-BDEFA39FD292
page(s)	S585-98
instance of	wds:Q37264464-127E5897-37A2-4069-9A05-F0C21F1B9BE5 wds:Q37264464-beae4b45-dd4e-4bcc-a172-964bdfe064e0
instance of	review article scholarly article
main subject	wds:Q37264464-6C94CE9A-E408-483E-844D-D9BF1CCAA5A8 wds:Q37264464-F53E5F22-1A64-410F-9F6B-05CE96A8AA1C
main subject	dyskinesia Parkinson's disease
PubMed ID	wds:Q37264464-73C4233B-F936-4286-A107-9245F47EA932
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/18781676
PubMed ID	18781676
published in	wds:Q37264464-56BF789E-A816-4883-879B-CDDB6A9B1FFC
published in	Movement Disorders
issue	wds:Q37264464-F958975F-2DA0-4212-8D39-B397FD24B8C9
volume	wds:Q37264464-C67BA9D8-6164-4DF1-B3A6-9331FD3A2410
issue	S3
volume	23 Suppl 3
DOI	wds:Q37264464-EF9BE0EF-AD77-49B9-8E21-4286723D59DD
DOI	http://dx.doi.org/10.1002/MDS.22022
DOI	10.1002/MDS.22022
skos:altLabel	Preventing and controlling dyskinesia in Parkinson's disease-A view of current knowledge and future opportunities (en)
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q37264464
is cites work of	Milestones in Parkinson's disease therapeutics Treating Parkinson's disease in the 21st century: can stem cell transplantation compete? The dopamine D(2) receptor partial agonist aplindore improves motor deficits in MPTP-treated common marmosets alone and combined with L-dopa

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 190 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software